Back
Nautilus Biotechnology, Inc. Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
34
NAUT
Nautilus Biotechnology, Inc.
Last Price:
$2.00
Seasonality Move:
-17.65%
Buy
60
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$784.09
Seasonality Move:
12.13%
Sell
34
Nautilus Biotechnology, Inc. (NAUT)
is a Sell
Is Nautilus Biotechnology, Inc. a Buy, Sell or Hold?
-
The current Nautilus Biotechnology, Inc. [NAUT] share price is $2.00. The Score for NAUT is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
NAUT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $783.71. The Score for REGN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NAUT Stock Price Chart
What is Nautilus Biotechnology, Inc.'s stock price today?
-
The Nautilus Biotechnology, Inc. share price today is $2.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NAUT is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $783.71Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
NAUT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 54.66 | Buy |
| Chaikin Money Flow: | 52338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.9 - 2.18) | Sell |
| Bollinger Bands (100): | (0.69 - 1.83) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 204.17 | Buy |
| Relative Strength Index (14 RSI): | 67.2 | Buy |
| Chaikin Money Flow: | -261329 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (720.67 - 774.53) | Buy |
| Bollinger Bands (100): | (555.56 - 709.04) | Buy |
NAUT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.92 | Buy |
| 20-day SMA: | 2 | Buy |
| 50-day SMA: | 1.77 | Buy |
| 200-day SMA: | 1.02 | Buy |
| 8-day EMA: | 1.95 | Buy |
| 20-day EMA: | 1.95 | Buy |
| 50-day EMA: | 1.68 | Buy |
| 200-day EMA: | 0.76 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 764.21 | Buy |
| 20-day SMA: | 747.28 | Buy |
| 50-day SMA: | 691.09 | Buy |
| 200-day SMA: | 601.8 | Buy |
| 8-day EMA: | 603.24 | Buy |
| 20-day EMA: | 348.3 | Buy |
| 50-day EMA: | 164.33 | Buy |
| 200-day EMA: | 44.8 | Buy |
Nautilus Biotechnology, Inc. Earnings Growth & NAUT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.03 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
Nautilus Biotechnology, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||